PLAT and ischemic stroke: Recombinant tissue plasminogen activator (rtPA; administered as the formulation alteplase) is the only approved thrombolytic treatment for ischaemic stroke, but only a small proportion of patients receive benefit.13 It is usually administered as a 10% intravenous bolus and the remaining 90% infused over 60 min.